-

Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member

Payne joins Hims & Hers board of directors to help the company further build on its leadership position within the personalized health and wellness space

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Christopher Payne to the company’s Board of Directors.

“Christopher brings extensive experience working directly with some of the world’s most innovative tech founders to drive incredible growth, by helping to bring their visions to life and achieve global scale,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “He has a history of innovating across industries, building trusted brands globally, and evolving businesses to meet shifting customer needs. I’m inspired by the work Christopher has led in his tenured career and he will bring incredible insight and knowledge to the board as we continue to scale and grow our health and wellness platform.”

Christopher Payne is a proven leader with more than three decades of software and technology experience. He previously served as the President and Chief Operating Officer of DoorDash from 2016 to 2023. Prior to his time at DoorDash, he served as the CEO of Tinder. He also served as Senior Vice President at eBay after he sold his company, Positronic, to the online retailer in 2008. Mr. Payne has also held leadership positions at Microsoft and Amazon, and currently serves on the board of directors of Gogo.

“With their health and wellness platform, Hims & Hers is at the forefront of transforming healthcare delivery. As a board member, I'll have the opportunity to influence how cutting-edge technology and personalized care can redefine access to great healthcare, especially in areas like weight management, dermatology, sexual health and mental health,” said Christopher Payne. “Andrew is one of health tech’s most forward-thinking industry leaders and together, I believe we can drive significant advancements in healthcare accessibility and innovation.”

With the appointment of Mr. Payne, the board of directors at Hims & Hers is now composed of ten directors, with backgrounds covering healthcare, medicine, consumer goods, online retail, and technology, among other areas.

About Hims & Hers Health, Inc

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.

Contacts

Jen Treadwell
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Versions

Contacts

Jen Treadwell
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, refe...

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across sexual health, hormone health, dermatology, weight loss, and mental health,...

Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims & Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligible Canadians. By combining Juniper's proven platform with the technology, data, and clinical infrastructure that has advance...
Back to Newsroom